<< Back To Home

SINGLE-ARM EVALUATION OF THE ACCUCIRC DEVICE FOR EARLY INFANT MALE CIRCUMCISION IN BOTSWANA

Thursday, 13th of March 2014 Print

SINGLE-ARM EVALUATION OF THE ACCUCIRC DEVICE FOR EARLY INFANT MALE CIRCUMCISION IN BOTSWANA

Top of Form

J Acquir Immune Defic Syndr. 2014 Mar 10. [Epub ahead of print]

 

Plank RM1, Wirth KE, Ndubuka NO, Abdullahi R, Nkgau M, Lesetedi C, Powis KM, Mmalane M, Makhema J, Shapiro R, Lockman S.

Author information

Abstract below; full text available to journal subscribers

Existing devices for early infant male circumcision (EIMC) have inherent limitations. We evaluated the newly developed AccuCirc device by circumcising 151 clinically well, full-term male infants with birth-weight ≥ 2.5 kg within the first 10 days of life from a convenience sample in two hospitals in Botswana. No major adverse events were observed. There was one local infection, five cases of minor bleeding and one case of moderate bleeding. In three cases the device made only partial incisions that were completed immediately by the provider without complications. Parental satisfaction was high: > 96% of mothers stated they would circumcise a future son. The pre-assembled, sterile AccuCirc kit has the potential to overcome obstacles related to supply chain management and on-site instrument disinfection that can pose challenges in resource-limited settings. In our study the AccuCirc was safe and it should be considered for programmatic EIMC in resource-limited settings.

41198198